Equities

Canopy Growth Corp

Canopy Growth Corp

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (CAD)14.81
  • Today's Change-0.16 / -1.07%
  • Shares traded4.07m
  • 1 Year change+4.30%
  • Beta1.7615
Data delayed at least 15 minutes, as of May 17 2024 21:18 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Canopy Growth Corporation is a cannabis and consumer packaged goods (CPG) company. The Company delivers innovative products with a focus on premium and mainstream cannabis brands, including Doja, 7ACRES, Tweed, and Deep Space. Its CPG portfolio includes gourmet wellness products by Martha Stewart CBD, and vaporizer technology made in Germany by Storz & Bickel. The principal activities of the Company are the production, distribution, and sale of a diverse range of cannabis and cannabinoid-based products for both adult-use and medical purposes under a portfolio of distinct brands in Canada. Its Canada cannabis segment includes the production, distribution, and sale of a diverse range of cannabis, hemp, and cannabis products in Canada. Its Rest-of-world cannabis segment includes the production, distribution, and sale of a diverse range of cannabis and hemp products internationally. Its Storz & Bickel segment includes the production, distribution, and sale of vaporizers.

  • Revenue in CAD (TTM)298.07m
  • Net income in CAD-1.10bn
  • Incorporated2009
  • Employees1.62k
  • Location
    Canopy Growth Corp1 Hershey DrSMITHS FALLS K7A 0A8CanadaCAN
  • Phone+1 (613) 599-9600
  • Fax+1 (613) 599-0018
  • Websitehttps://www.canopygrowth.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Aurora Cannabis Inc266.97m-125.07m547.76m1.13k--0.9261--2.05-3.39-3.636.8310.850.291.966.57236,259.30-14.60---17.65--1.93---50.34--2.45-23.120.1562--------------
Knight Therapeutics Inc332.21m-17.44m617.84m725.00--0.811519.041.86-0.1726-0.17263.167.530.33011.843.51458,215.20-1.730.3477-1.980.415646.2346.28-5.251.692.520.10620.08430.0011.8092.2443.68--20.79--
Terrascend Corp447.14m-118.12m716.63m742.00--2.78--1.60-0.4133-0.41741.570.88470.48423.2828.41---11.49-28.09-15.63-36.1950.0846.65-23.73-69.160.24341.000.4656--28.04126.9870.03---0.8878--
Jamieson Wellness Inc667.49m36.70m1.09bn1.23k31.022.5119.581.630.84810.848115.6810.500.6042.295.62--3.195.943.686.9434.1335.885.289.251.544.110.500449.5123.5316.16-9.3312.41-4.1816.19
Cronos Group Inc126.61m-73.68m1.52bn626.00--1.04--12.03-0.1933-0.20370.33223.830.0822.125.46---4.846.43-4.977.1114.47-10.54-59.00147.0727.28--0.00--0.567248.4054.99---50.99--
Canopy Growth Corp298.07m-1.10bn1.64bn1.62k--2.26--5.49-19.37-21.884.396.570.13611.754.38183,880.90-50.79-24.88-63.02-27.0011.90-1.42-373.19-355.421.40-0.81930.56---21.0538.89-957.32---43.17--
Bausch Health Companies Inc12.20bn-619.21m3.33bn20.27k----3.110.2726-1.69-1.6933.31-4.140.34251.834.80601,964.90-1.83-2.74-2.27-3.3170.8171.59-5.34-9.780.85361.191.01--7.790.884-163.11--2.97--
Curaleaf Holdings Inc1.84bn-322.40m4.93bn5.65k--4.06--2.68-0.4418-0.51332.521.880.41983.0724.81325,875.10-7.65-7.38-9.75-8.6745.4543.30-18.23-18.120.35790.35360.4585--5.5877.2111.09--8.92--
Data as of May 17 2024. Currency figures normalised to Canopy Growth Corp's reporting currency: Canadian Dollar CAD
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.